YU46151B - Postupak za dobijanje 7-/2-(5-amino-1, 2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/3-/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata - Google Patents

Postupak za dobijanje 7-/2-(5-amino-1, 2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/3-/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Info

Publication number
YU46151B
YU46151B YU60085A YU60085A YU46151B YU 46151 B YU46151 B YU 46151B YU 60085 A YU60085 A YU 60085A YU 60085 A YU60085 A YU 60085A YU 46151 B YU46151 B YU 46151B
Authority
YU
Yugoslavia
Prior art keywords
formula
hydrogen
amino
group
protecting group
Prior art date
Application number
YU60085A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU60085A (en
Inventor
H. Yamashita
M. Oka
J. Okumura
T. Naito
Original Assignee
Bristol-Myers Squibb Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Co. filed Critical Bristol-Myers Squibb Co.
Priority to YU118987A priority Critical patent/YU46213B/sh
Publication of YU60085A publication Critical patent/YU60085A/xx
Publication of YU46151B publication Critical patent/YU46151B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78—Separation; Purification; Stabilisation; Use of additives
    • C07C45/79—Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU60085A 1984-04-09 1985-04-09 Postupak za dobijanje 7-/2-(5-amino-1, 2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/3-/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata YU46151B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
YU118987A YU46213B (sh) 1984-04-09 1987-06-25 Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-09 1984-04-09

Publications (2)

Publication Number Publication Date
YU60085A YU60085A (en) 1987-12-31
YU46151B true YU46151B (sh) 1993-05-28

Family

ID=24393575

Family Applications (2)

Application Number Title Priority Date Filing Date
YU60085A YU46151B (sh) 1984-04-09 1985-04-09 Postupak za dobijanje 7-/2-(5-amino-1, 2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/3-/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata
YU118987A YU46213B (sh) 1984-04-09 1987-06-25 Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU118987A YU46213B (sh) 1984-04-09 1987-06-25 Postupak za dobijanje 7-/2-(5-amino-1,2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/-3 -/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata

Country Status (31)

Country Link
JP (4) JPS615084A (es)
KR (1) KR870002166B1 (es)
AR (1) AR244694A1 (es)
AT (1) AT388735B (es)
AU (2) AU580990B2 (es)
BE (1) BE902148A (es)
CA (3) CA1276929C (es)
CH (1) CH669197A5 (es)
DD (3) DD249024A5 (es)
DE (1) DE3512225A1 (es)
DK (1) DK155985A (es)
ES (4) ES8607318A1 (es)
FI (1) FI84830C (es)
FR (1) FR2563832B1 (es)
GB (3) GB2157293B (es)
GR (1) GR850883B (es)
HU (2) HU193750B (es)
IE (2) IE58408B1 (es)
IL (1) IL74826A (es)
IT (1) IT1190353B (es)
LU (1) LU85840A1 (es)
MY (1) MY101940A (es)
NL (1) NL192925C (es)
NZ (1) NZ211659A (es)
OA (1) OA07985A (es)
PT (1) PT80246B (es)
RU (1) RU2056425C1 (es)
SE (4) SE466205B (es)
SU (4) SU1367858A3 (es)
YU (2) YU46151B (es)
ZA (1) ZA852236B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (ja) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd 新規セフエム化合物及びその製造法
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
ATE114657T1 (de) * 1985-12-26 1994-12-15 Eisai Co Ltd Cephalosporin-verbindungen.
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
JPH085897B2 (ja) * 1986-11-06 1996-01-24 エーザイ株式会社 ３−プロペニルセフェム誘導体
FR2622585B1 (fr) * 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
DE68928174T2 (de) * 1988-03-16 1997-12-18 Eisai Co Ltd Verfahren zur Herstellung von Cephemderivaten
JPH0699449B2 (ja) * 1988-03-16 1994-12-07 エーザイ株式会社 セフェム誘導体の合成中間体
FR2655042B1 (fr) * 1989-11-29 1994-01-21 Adir Cie Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663332B1 (fr) * 1990-06-15 1997-11-07 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical propenyle substitue par un ammonium quaternaire, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (de) * 1991-08-21 1993-06-25 Biochemie Gmbh Neues verfahren und neue zwischenprodukte zur herstellung von 7-aminocephalosporansaeurederivaten
JPH0741484A (ja) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk セフェム化合物及び抗菌剤
KR100248851B1 (ko) * 1994-08-16 2000-04-01 이치로 키타사토 신규 세펨 유도체
PL345266A1 (en) 1998-06-22 2001-12-03 Hoffmann La Roche Propenyl cephalosporin derivatives
EP1666483B1 (en) 2003-09-09 2011-08-17 Nippon Chemical Industrial Company Limited Process for producing 3-chloromethyl-3-cephem derivative

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (de) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathiaverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend solche Verbindungen und Verwendung von letzteren
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (es) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (es) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
NL8501002A (nl) 1985-11-01
JPS61143390A (ja) 1986-07-01
FR2563832A1 (fr) 1985-11-08
SU1375140A3 (ru) 1988-02-15
SE470260B (sv) 1993-12-20
ES551551A0 (es) 1987-07-01
KR870002166B1 (ko) 1987-12-14
HU193750B (en) 1987-11-30
ZA852236B (en) 1985-11-27
LU85840A1 (fr) 1985-12-16
SE8901225D0 (sv) 1989-04-06
ES8800949A1 (es) 1987-12-01
FR2563832B1 (fr) 1989-08-18
JPS61143391A (ja) 1986-07-01
CA1340672C (en) 1999-07-20
JPH0357106B2 (es) 1991-08-30
ES8706694A1 (es) 1987-07-01
ES8607318A1 (es) 1986-06-16
AR244694A1 (es) 1993-11-30
JPS61143387A (ja) 1986-07-01
JPH0350754B2 (es) 1991-08-02
SE466205B (sv) 1992-01-13
HU204277B (en) 1991-12-30
GB2157293B (en) 1988-10-05
SE8501680D0 (sv) 1985-04-03
FI84830B (fi) 1991-10-15
FI851379L (fi) 1985-10-10
CA1276929C (en) 1990-11-27
SU1487814A3 (ru) 1989-06-15
SE8501680L (sv) 1985-10-10
ATA103985A (de) 1989-01-15
SU1436882A3 (ru) 1988-11-07
NL192925B (nl) 1998-01-05
GB8721347D0 (en) 1987-10-14
GB2157293A (en) 1985-10-23
OA07985A (fr) 1987-01-31
DD251752A5 (de) 1987-11-25
MY101940A (en) 1992-02-15
IL74826A0 (en) 1985-07-31
PT80246B (pt) 1987-10-20
GB8721346D0 (en) 1987-10-14
DD249024A5 (de) 1987-08-26
HUT37622A (en) 1986-01-23
ES551550A0 (es) 1987-06-01
JPS615084A (ja) 1986-01-10
DD236735A5 (de) 1986-06-18
IL74826A (en) 1990-01-18
DK155985D0 (da) 1985-04-03
CH669197A5 (de) 1989-02-28
JPH0262557B2 (es) 1990-12-26
GB2194790A (en) 1988-03-16
PT80246A (en) 1985-05-01
ES542013A0 (es) 1986-06-16
IE850866L (en) 1985-10-09
SE8901224D0 (sv) 1989-04-06
GB8508846D0 (en) 1985-05-09
JPH0351716B2 (es) 1991-08-07
DE3512225A1 (de) 1985-10-17
IT1190353B (it) 1988-02-16
NZ211659A (en) 1988-11-29
BE902148A (fr) 1985-10-09
FI84830C (fi) 1992-01-27
GB2194789B (en) 1988-10-12
SE505256C2 (sv) 1997-07-21
SE8901224L (sv) 1989-04-06
IE58403B1 (en) 1993-09-22
AT388735B (de) 1989-08-25
KR850007424A (ko) 1985-12-04
SE8901226D0 (sv) 1989-04-06
GB2194789A (en) 1988-03-16
AU610278B2 (en) 1991-05-16
ES8706155A1 (es) 1987-06-01
GR850883B (es) 1985-11-25
YU60085A (en) 1987-12-31
AU580990B2 (en) 1989-02-09
CA1340638C (en) 1999-07-06
IT8520267A0 (it) 1985-04-05
IE58408B1 (en) 1993-09-22
SE8901226L (sv) 1989-04-06
GB2194790B (en) 1988-10-05
ES557060A0 (es) 1987-12-01
DK155985A (da) 1985-10-10
DE3512225C2 (es) 1990-02-22
NL192925C (nl) 1998-05-07
FI851379A0 (fi) 1985-04-04
SU1367858A3 (ru) 1988-01-15
YU46213B (sh) 1993-05-28
AU4086285A (en) 1985-10-17
AU2504188A (en) 1989-03-02
YU118987A (en) 1988-10-31
RU2056425C1 (ru) 1996-03-20
SE8901225L (sv) 1989-04-06
SE470259B (sv) 1993-12-20

Similar Documents

Publication Publication Date Title
YU46151B (sh) Postupak za dobijanje 7-/2-(5-amino-1, 2,4-tiadiazol-3-il)-2-(supstituisani)iminoacetamido/3-/3-(kvaternerni amonio)-1-propen-1-il/-3-cefem-4-karboksilata
ES8704955A1 (es) Un proceso para la produccion de un compuesto de cefalospo- rina
SE453092B (sv) Nya cefalosporinderivat, forfarande for framstellning derav samt kompositioner derav
NZ247277A (en) Imidazolyl-substituted arylsulphonylamino derivatives of piperidine; methods of preparation and pharmaceutical compositions thereof
ES455089A1 (es) Procedimiento de preparacion de nuevas oximas derivadas del acido 7-aminotioazolil-acetamido-cefalosporanico.
JPS56128767A (en) Substituted imidazole derivative, its manufacture and medicine as effective component
FI820140L (fi) Foerfarande foer framstaellning av substituerade imidazolderivat
ES8203845A1 (es) Procedimiento para preparar derivados de piridoxina
ES8200685A1 (es) Un procedimiento para la preparacion de derivados acidos penemcarboxilicos.
NO970427L (no) Fremgangsmåte for fremstilling av antimikrobielle forbindelser
CA2088742A1 (en) Benzimidazole and imidazopyridine derivatives and their application
SE453091B (sv) Nya cefalosporinderivat, forfarande for framstellning derav samt kompositioner derav
KR860000302A (ko) 항균화합물의 제조방법
ES8706144A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
JPS6485A (en) Novel cephalosporin derivative
YU46647B (sh) Postupak za dobijanje hinolinskih derivata
US4528285A (en) Methylenedioxy quino-benzothiazine derivatives
ATE212637T1 (de) Anitbiotisch wirksame cephalosporine und verfahren zu ihrer herstellung
CA1268183A (en) INTERMEDIATES OF PHOSPHORANE USED IN THE PREPARATION OF ANTIBIOTIC PENEMS
EP0081971A2 (en) Novel cephalosporin compound and process for preparing the same
ES8304973A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiocarbapenem 3-sustituidos.
JPS5762287A (en) Cephalosporin compound for oral administration
ES8204729A1 (es) Procedimiento para la preparacion de acidos de 2-(3'-tienil)propionicos 5'-sustituidos
EP0482342A3 (en) Hypocholesterolemic unsymmetrical dithiol ketals
JPS56128787A (en) Cephalosporin derivative and its preparation